SLC2A4 and polycystic ovary syndrome: study, the therapeutic effect of berberine in reducing PCOS and IR symptoms in PCOS rats was associated with a mechanism involving increased GLUT4 regulation via PI3K/Akt activation and suppression of the MAPK pathway [47].